Ege David S.
- SEC CIK
- 0001829360
No open-market purchases or sales filed in the past year.
Current role at each company
- MCRB Seres Therapeutics, Inc.See Remarksas of Aug 19, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ege David S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 (view filing) | Aug 16 | 3 days | Ege David S.See Remarks | SSale | −1.13K | $0.84 | −$947.52 | −1.4%77.6K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Ege David S.See Remarks | SSale | −1.09K | $0.94 | −$1.02K | −1.4%75.7K after | 10b5-1 |
| Feb 16, 2024 (view filing) | Feb 16 | Same day | Ege David S.See Remarks | SSale | −5.01K | $1.08 | −$5.41K | −6.4%73.9K after | 10b5-1 |
| Oct 31, 2023 (view filing) | Oct 30 | 1 day | Ege David S.See Remarks | SSale | −4.07K | $1.35 | −$5.49K | −5.7%67.0K after | 10b5-1 |
| May 1, 2023 (view filing) | Apr 28 | 3 days | Ege David S.See Remarks | SSale | −7.04K | $5.19 | −$36.5K | −10.5%59.7K after | |
| Oct 31, 2022 (view filing) | Oct 31 | Same day | Ege David S.See Remarks | SSale | −5.01K | $7.93 | −$39.7K | −9.7%46.7K after |